Casipong, Seth Michael .
HRN: 23-88-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
10/12/2023
10/16/2023
PO
3.5ml
OD
PCAP-B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes